-
-
REFERENCES
[1] AACR Cancer Research Catalyst: https://www.aacr.org/professionals/blog/. [2] Bertagnolli, M. M., Carnival, D., and Jaffee, E. M. (2023). Achieving the goals of the cancer moonshot requires progress against all cancers. Cancer Discov. 13: 1049−1052. DOI: 10.1158/2159-8290.CD-23-0344. [3] The ASCO Post: https://ascopost.com/news. [4] Tarantino, P., Ricciuti, B., Pradhan, S. M., et al. (2023). Optimizing the safety of antibody–drug conjugates for patients with solid tumours. Nat. Rev. Clin. Oncol. 20: 558-576. DOI: 10.1038/s41571-023-00783-w. [5] Li, J., Chen, X. X., Lu, A. P., et al. (2023). Targeted protein degradation in cancers: Orthodox PROTACs and beyond. The Innovation 4: 100413. DOI: 10.1016/j.xinn.2023.100413. -
ABOUT THIS ARTICLE
Cite this article:
Wang H. (2023). Highlights from AACR 2023 Annual Meeting. The Innovation Medicine 1(1), 100003. https://doi.org/10.59717/j.xinn-med.2023.100003
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Wang H. (2023). Highlights from AACR 2023 Annual Meeting. The Innovation Medicine 1(1), 100003. https://doi.org/10.59717/j.xinn-med.2023.100003
Format
Content
DownLoad:
-
Figure 1.
Showcases the six highlights presented at the AACR 2023 annual meeting
